#sun pharma

💎 HMDA With RERA Approved projects

💎* Venus Grand city*(Venture name)

💎50 Acres Venture

💎Plot sizes min 150 sq.yds & above.

💎50% Bank loan available.

💎Spot registration.

💎Clear title.

💎 ISO certified company.

💎 Rachakonda commissionerate.

💎 Bachpan school backside.

💎Very near to Basavapur Reservoir.

💎Very near to Aiims.

💎 Municipal head quarters.

2*💎 Bhuvanagiri Anamtharam Village.

💎 HMDA With RERA Approved project.

💎* Highway Imperial (Venture name)

💎15 Acres project

💎Beside Sri Vasthalya Engineering college.

💎 Nearby 5 famous colleges.

💎 Nearby Renuka yellamma temple.

💎 Service road facing Venture.

💎Plot sizes min 167 sq.yds & above.

💎With 50% bank loan fecility.

💎Very near to Aiims.

3*💎 Gajwel Highway Rusthpur Village.

💎 DTCP with RERA Approved project.

💎5 Acres project.

💎*Silver Oak*( Venture name)

💎Very near to Basavapur Reservoir.

💎 National Highway 161AA.

💎 Minimum plot sizes from 150 sq yds.

💎 HMDA border.

💎150ft road facing Venture.

4*💎 Bibinagar Brahmanapalli Village road.

💎11Acres project.

💎 HMDA With RERA Approved project.

💎*Royal Avenue ( Venture name)

💎Ready to construction.

💎Plot sizes min 167 sq.yds & above.

💎Hindware company backside.

💎100ft road facing Venture.

💎 Valigonda to Chityaala connectivity road.

💎Very near to Aiims.

💎 Very near to Bibinagar railway station.

5*💎Keesara Bhogaram.

💎Villa project.

💎10 Acres project .

💎Plot sizes min 180 sq.yds & 200 sq.yds.

💎From keesara to 2km

ఇలాంటి మరిన్ని పోస్ట్‌లను చూడటానికి మరియు తెలంగాణ రియల్ ఎస్టేట్ ఏజెంట్స్ సంక్షేమ సంఘం ( TREASS ) చేరడానికి, ఇక్కడ క్లిక్ చేయండి

Reluctant, very reluctant...

In 2015, Dilip Shanghvi briefly toppled Mukesh Ambani to become the richest Indian on the Forbes list. But he is not a household name as some of his contemporaries are. Outside a small circle of insiders, even to whom he is an enigma, hardly anybody knows him. He likes it that way. He works hard to keep it that way.

Business journalist, Soma Das, wanted to know him. But there was no satisfactory content available about the kind of person that he was. So she decided to write the book she wanted to read. “The inspiration for this book didn’t pop into my head suddenly one day. It sneaked in, nagged me and haunted me till I yielded,” she says.

That's when she encountered the legendary reluctance of Dilip Sanghavi. He apparently told her, "Why are you working so hard for me? Why don't you write about somebody more interesting, like Sunil Mittal? My life is not so interesting."

This, from a man who started with INR 10000, borrowed from his father, in 1982, to become the largest pharma company in India, the fifth largest in the world, the richest self-made man in India and a Padma Shri.

That's how reluctant he was. So Soma Das aptly named his biography - The reluctant billionaire. I have not read it. But I have read excerpts from it.

1. Dilip Shanghvi is known for his frugal nature and simple living. He loved to go to simple joints like Ram Ashray, a South Indian tiffin center in Matunga, on Sundays. One day, while he was in one such small eatery, some one walked up to him and said, "You know, you look a lot like Dilip Shanghvi."

2. He used to learn by what he called the Ekalavya-Dronacharya method - learn in-absentia. He says, he would read up and study the methods of successful people, like Dhirubhai Ambani or U.N.Mehta, founder of Torrent Group and implement learnings from their lives.

In 2014, Dilip Shanghvi invested INR 1400 crores of his personal wealth in a struggling company called Suzlon. Suzlon is still struggling. It narrowly escaped bankruptcy earlier this year. Will Suzlon be Dilip Shangavi's Waterloo or will it turn around one day? I hope...just hope...

Alors que la croissance économique indienne montre des signes d’essoufflement, les grandes entreprises du pays se tournent massivement vers l’étranger pour réaliser des acquisitions stratégiques. En avril dernier, Sun Pharmaceuticals a conclu le rachat d’Organon & Co pour 11,75 milliards de dollars, marquant la plus importante opération transfrontalière d’une firme indienne depuis près de vingt…

https://img.etimg.com/thumb/msid-127819967,width-1200,height-630,imgsize-42404,overlay-etmarkets/articleshow.jpg Sun Pharma on Saturday reported a 15% increase in its third quarter sales to Rs 15,469 crore, while net profit was up 16% year-on-year to Rs 3,368 crore, driven by growth across its branded businesses in India, emerging markets and global innovative medicines. “Our innovative product…

#US 🍘

#Unit 🍀

#Recalls ✨

#Over 👾

#17000 🌸

#Units☀️

#Antifungal ♑

#Shampoo🫧

Sun Pharma’s US Unit Recalls Over 17,000 Units of Antifungal Shampoo

https://amoghavarshaonline.blogspot.com/2025/12/sun-pharmas-us-unit-recalls-over-17000.html